Evaluation of the reinforcing and discriminative stimulus effects of the N-methyl-D-aspartate competitive antagonist NPC 17742 in rhesus monkeys

Behavioural Pharmacology

Volumn 8, Issue 5, 1997, Pages 396-407

  Nicholson, K L ^a   Jones, H E ^a   Balster, R L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug discrimination; Monkey; NMDA receptor; NPC 17742; Phencyclidine; Self administration

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; AMINO ACID; AMINO ACID RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID; PHENCYCLIDINE;

ANIMAL; ARTICLE; BINDING COMPETITION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; MACACA; MALE; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; REINFORCEMENT;

AMINO ACIDS; ANIMALS; BINDING, COMPETITIVE; DISCRIMINATION (PSYCHOLOGY); EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MACACA MULATTA; MALE; N-METHYLASPARTATE; PHENCYCLIDINE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 0031240637     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199710000-00004     Document Type: Review

References (57)

1. Balster RL (1990) Perception of drug effects. In: Comparative Perception, Vol. I, Basic Mechanisms (Eds MA Berkley and WC Stebbins), pp. 127-153. John Wiley and Sons Inc., New York.
2. Balster RL (1991) Discriminative stimulus properties of phencyclidine and other NMDA antagonists. In: Drug Discrimination: Applications to Drug Abuse Research (Eds RA Glennon, TUC Järbe and J Frankenheim), pp. 163-180. National Institute on Drug Abuse Research Monograph Series 116, DHHS Publication No.(ADM) 92-1878, US Government Printing Office, Washington.
3. Balster RL and Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. Journal of the Experimental Analysis of Behavior, 20, 119-129.
4. Balster RL, Johanson CE, Harris RT and Schuster CR (1973) Phencyclidine self-administration in the rhesus monkey. Pharmacology Biochemistry and Behavior, 1, 167-172.
5. Balster RL, Nicholson KL and Sanger DJ (1994) Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug and Alcohol Dependence, 35, 211-216.
6. Baron SP and Woods JH (1995) Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology, 118, 42-51.
7. Beardsley PM and Balster RL (1993) The effects of delay of reinforcement and dose on the self-administration of cocaine and procaine in rhesus monkeys. Drug and Alcohol Dependence, 34, 37-43.
8. Beardsley PM, Hayes BA and Balster RL (1990) The self-administration of MK-801 can depend upon drug-reinforcement history and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 252, 953-959.
9. Bobelis DJ and Balster RL (1993) Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2- cyclohexyl)-7-phosphonoheptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. Journal of Pharmacology and Experimental Therapeutics, 264, 845-853.
10. Borchard RE, Barnes CD and Eltherington LG (1991) Drug Dosage in Laboratory Animals. A Handbook, 3rd edn. Telford Press, Caldwell, NJ.
11. Brady KT, Balster RL and May EL (1982) Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats. Science, 212, 178-180.
12. Butelman ER, France CP and Woods JH (1991) The discriminative stimulus effects of MK-801 in pigeons. Behavioural Pharmacology, 2, 79-86.
13. Carlezon Jr WA and Wise RA (1996a) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. Journal of Neuroscience, 16, 3112-3122.
14. Carlezon Jr WA and Wise RA (1996b) Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology, 128, 413-420.
15. Chen M, Bullock R, Graham DI, Frey P, Lowe D and McCulloch J (1991) Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia. Annals of Neurology, 30, 62-70.
16. Compton RD, Contreras PC, O'Donahue TL and Monahan JB (1987) The N-methyl-D-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidine-like behavioral effects in rats. European Journal of Pharmacology, 136, 133-134.
17. Ferkany JW, Kyle DJ, Willetts J, Rzeszotarski WJ, Guzewska ME, Ellenberger SR, Jones SM, Sacaan AI, Snell LD, Borosky S et al. (1989) Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist. Journal of Pharmacology and Experimental Therapeutics, 250, 100-109.
18. Ferkany JW, Hamilton GS, Patch RJ, Huang Z, Borosky SA, Bednar DL, Jones BE, Zubrowski R, Willetts J and Karbon EW (1993) Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. Journal of Pharmacology and Experimental Therapeutics, 264, 256-264.
19. France CP, Woods JH and Ornstein P (1989) The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. European Journal of Pharmacology, 159, 133-139.
20. France CP, Moerschbaecher JM and Woods JH (1991) MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination. Journal of Pharmacology and Experimental Therapeutics, 257, 727-734.
21. Gold LH and Balster RL (1993) Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline. European Journal of Pharmacology, 230, 285-292.
22. Griffiths RR, Lukas SE, Bradford LD, Brady JV and Snell JD (1981) Self-injection of barbiturates and benzodiazepines in baboons. Psychopharmacology, 75, 101-109.
23. Griffiths RR, Lamb RJ, Sannerud CA, Ator NA and Brady JV (1991) Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology, 103, 154-161.
24. Hamilton GS, Huang Z, Narayanan BA, Patch RJ and Ferkany JW (1993) Enzymatic asymmetric synthesis of (2R,4R,5S) 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid, a potent, selective and competitive NMDA antagonist. Bioorganic and Medicinal Chemistry Letters, 3, 27-32.
25. Herrling PL, Emre M and Watkins JC (1997) D-CPPene (SDZ EAA-494) - A competitive NMDA antagonist: pharmacology and results in humans. In: Excitatory Amino Acids - Clinical Results with Antagonists (Ed. PL Herrling), pp. 7-21, Academic Press Ltd, San Diego.
26. Jackson A and Sanger DJ (1988) Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors? Psychopharmacology, 96, 87-92.
27. Johanson CE and Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bulletin on Narcotics, 30, 43-54.
28. Kato S, Wakasa Y and Yanagita T (1987) Relationship between minimum reinforcing doses and injection speed in cocaine and pentobarbital self-administration in crab-eating monkeys. Pharmacology Biochemistry and Behavior, 28, 407-410.
29. Koek W and Colpaert FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. Journal of Pharmacology and Experimental Therapeutics, 252, 349-357.
30. Koek W and Woods JH (1988) Correlations between phencyclidine-like activity and N-methyl-D-aspartate antagonism: behavioral evidence. In: Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology (Eds EF Domino and J-M Kamenka), pp. 357-372, NPP Books, Ann Arbor, MI.
31. Koek W, Woods JH and Ornstein P (1986) Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate. Life Science, 39, 973-978.
32. Koek W, Woods JH, Jacobson AE and Rice KC (1987a) Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP. Psychopharmacology, 93, 437-442.
33. Koek W, Woods JH, Mattson MV, Jacobson AE and Mudar PJ (1987b) Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: structure-activity studies. Neuropharmacology, 91, 297-304.
34. Koek W, Woods JH and Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 245, 968-974.
35. Koek W, Woods JH and Colpaert FC (1990) N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. Journal of Pharmacology and Experimental Therapeutics, 253, 1017-1025.
36. Mansbach RS and Balster RL (1991) Pharmacological specificity of the phencyclidine discriminative stimulus in rats. Pharmacology Biochemistry and Behavior, 39, 971-975.
37. 9-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behavioural Pharmacology, 5, 219-225.
38. Meisch RA (1987) Factors controlling drug reinforced behavior. Pharmacology Biochemistry and Behavior, 27, 367-371.
39. Morse WH (1976) Introduction: the control of behavior by consequent drug injections. Pharmacological Reviews, 27, 301-305.
40. Nishikawa T, Kirsch JR, Koehler RC, Miyabe M, Traystman RJ (1994) Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats. Stroke, 25, 2258-2264.
41. Patel S, Chapman AG, Graham J, Meldrum BS and Frey P (1990) Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphono-prop-2-enyl)piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Epilepsy Research, 7, 3-10.
42. Rogawski MA (1992) The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs, 44, 279-292.
43. Slifer BL and Balster RL (1983) Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 225, 522-528.
44. Spealman RD and Kelleher RT (1979) Behavioral effects of self-administered cocaine: responding maintained alternately by cocaine and electric shock in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 210, 206-214.
45. Stretch R, Gerber GJ and Lane E (1976) Cocaine self-injection behavior under schedules of delayed reinforcement in monkeys. Canadian Journal of Physiology and Pharmacology, 54, 632-638.
46. Tricklebank MD, Singh L, Oles RJ, Preston C and Iversen SD (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. European Journal of Pharmacology, 167, 127-135.
47. Wiley JL and Balster RL (1994) Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle. Psychopharmacology, 116, 266-272.
48. Wiley JL, Li H and Balster RL (1997) Discriminative stimulus effects of site-selective N-methyl-D-aspartate antagonists in NPC 17742-trained rats and squirrel monkeys. Psychopharmacology, in press.
49. Willetts J and Balster RL (1988) The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats. Neuropharmacology, 21, 1249-1256.
50. Willetts J, Bobelis DJ and Balster RL (1989) Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626. Psychopharmacology, 99, 458-462.
51. Willetts J, Balster RL and Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Science, 11, 423-428.
52. Willetts J, Clissold DB, Hartman TL, Brandsgaard RR, Hamilton GS and Ferkany JW (1993) Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist. Journal of Pharmacology and Experimental Therapeutics, 265, 1055-1062.
53. Winger G, France CP and Woods JH (1991) Intravenous self-injection in rhesus monkeys: comparison of CGS 19755 and phencyclidine-like compounds. In: Excitatory Amino Acids (Eds BS Meldrum, F Moroni, RP Simon and JH Woods), pp. 539-545, Raven Press Ltd, New York.
54. Winger G, Stitzer ML and Woods JH (1975) Barbiturate-reinforced responding in rhesus monkeys: Comparisons of drugs with different durations of action. Journal of Pharmacology and Experimental Therapeutics, 195, 505-514.
55. Woods JH (1989) Consciousness. Pharmacology Biochemistry and Behavior, 31, 1081(abstr.).
56. Young AM and Herling S (1986) Drugs as reinforcers: studies in laboratory animals. In: Behavioral Analysis of Drug Dependence (Eds SR Goldberg and IP Stolerman), pp. 9-67, Academic Press, Orlando.
57. Young AM and Woods JH (1981) Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. Journal of Pharmacology and Experimental Therapeutics, 218, 720-727.